CASE REPORT OPEN ACCESS

International Journal of Surgery Case Reports 4 (2013) 579582

Contents lists available at SciVerse ScienceDirect

International Journal of Surgery Case Reports

journal homepage: www.elsevier.com/locate/ijscr

Adenocarcinoma in an ano-vaginal stula in Crohns disease

Maryam Alfa-Wali , Angela Atinga, Yasser Mohsen, Andrew Anthony, Alistair Myers
Hillingdon Hospital NHS Foundation Trust, United Kingdom

a r t i c l e

i n f o

a b s t r a c t
INTRODUCTION: Fistulas are a relatively common occurrence in Crohns disease (CD), and often present early in the disease process. Additionally, patients suffering from either CD or ulcerative colitis are shown to have an increased risk of colorectal malignancies compared with the general population. PRESENTATION OF CASE: We present a case of adenocarcinoma in an ano-vaginal stula in a patient with longstanding CD. DISCUSSION: Various pathogenic mechanisms for the development of carcinoma in stulas have been suggested, but there is no consensus and indeed this risk may be cumulative. In this case report, we also discuss the pathogenesis of mucinous adenocarcinoma in stulas secondary to CD. CONCLUSION: Better detection of adenocarcinoma in patients presenting with persistent non-resolving stulas in the presence of CD should be undertaken with regular biopsies following examinations under anaesthetic of the anorectum. 2013 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.

Article history: Received 29 October 2012 Received in revised form 10 April 2013 Accepted 13 April 2013 Available online 18 April 2013 Keywords: Crohns disease Fistulae Mucinous Adenocarcinoma

1. Introduction Crohns disease (CD) is known to be associated with perianal disease in the form of stulas and abscesses. The risk of malignancy with CD is also well recognised however the location is variable and not always predictable. A case of a mucinous adenocarcinoma at an unusual location is presented here.

2. Presentation of case A 53-year-old female with a 30-year history of Crohns disease (CD), and previous ileo-colic resection 15 years before, developed new right-sided abdominal symptoms. She was referred to a gastroenterologist by the general practitioner. Physical examination to exclude perianal sepsis before starting cyotokine-modulating monoclonal antibody therapy showed a 2 cm 4 cm perianal lump at the anal verge in the 6 oclock position. Her disease had been quiescent in the period since her resection but in the months before presenting to us with the perianal lesion, she was treated with azathioprine and a reducing dose of prednisolone. Her past medical history included cervical cancer 16 years prior, which was treated with surgery and radiotherapy (the notes for which were not able to be retrieved from the institution where she was treated due to its closure). She had no obstetric history or history of human immunodeciency syndrome and smoked 5 cigarettes per day.

Corresponding author at: Hillingdon NHS Foundation Trust, Pield Heath Road, UUB3 8NN, United Kingdom. Tel.: +44 01895 238282; fax: +44 01895 811687. E-mail addresses: [email protected], [email protected] (M. Alfa-Wali).

A magnetic resonance image (MRI) of the abdomen and pelvis following identication of the lesion demonstrated a complex stula with an inter-sphincteric uid collection on the left side in the mid anal canal. This communicated with a Y shaped defect extending into the perineal body and vaginal introitus. In addition, a separate 2.7 cm cystic collection representing the lump seen clinically was identied supercially in the midline of the natal cleft, posterior to the anal canal (Fig. 1). In the abdomen, there was clear evidence of active colitis affecting the majority of the colon and short segment of the neo-terminal ileum. Colonoscopy revealed a neo-terminal ileal stricture, which histologically showed ulceration and evidence of active chronic colitis with rectal sparing, but no evidence of malignancy. A computed tomography (CT) scan of the chest, abdomen and pelvis did not show any evidence of metastatic disease. She subsequently underwent an examination under anaesthetic (EUA) of the anorectum and excision biopsy of the perianal lesion, which connected with the stula at the 5 oclock position (Fig. 2). At this time the stula was not found to connect with the lower posterior vagina. The histopathology of the excised lump showed a mucin-lled cyst lined with dysplastic epithelium and a second opinion was sought to review the histology. In the opinion of one pathologist (NS), this represented a mucinous well-differentiated adenocarcinoma arising in a stula in the context of chronic inammatory bowel disease (Fig. 3). Management options were discussed with the patient including the need for surgery for her reactivated ileo-colonic CD. The option of radiotherapy was discussed, however the multi-disciplinary team (MDT) and the patient were keen to avoid this given the unknown previous treatment for the cervical cancer and the risks of radiation enteritis in a Crohns patient which may then predispose to short gut syndrome. In more than one MDT meeting,

2210-2612/$ see front matter 2013 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved. http://dx.doi.org/10.1016/j.ijscr.2013.04.007

CASE REPORT OPEN ACCESS

580 M. Alfa-Wali et al. / International Journal of Surgery Case Reports 4 (2013) 579582

Fig. 1. The T2 images MRI of the abdomen and pelvis showing (a) the cystic collection in the midline of the natal cleft and (b) the Y shaped uid connection tract. Fig. 2. The perianal lesion (a) before and (b) after excision.

together with the patient, the decision was made to perform an open ileo-panproctocolectomy with a wide ischioanal fossa excision and posterior vaginectomy with a perianal reconstruction using a pedicled rectus abdominis ap. An EUA of the rectum prior to laparotomy revealed the secretion of mucin on digital rectal examination (Fig. 4). The patient underwent an ileo-panproctocolectomy with a left vertical rectus abdominis (VRAM) reconstruction (as there was a right sided scar from previous surgery), small bowel resection, right salphingectomy, posterior vaginectomy and ileostomy. The small bowel resection was necessitated by the presence of a Crohns mass involving the right fallopian tube. Post-operatively she required high dependency unit care, and had a number of complications including non-healing of the end ileostomy and enteric content contaminated the extensive dissection cavity associated with the left VRAM donor site. This was drained surgically and healed over a number of weeks. She was readmitted within a month with acute renal failure due to a high output ileostomy and then with a pulmonary embolus 6 weeks post-operatively despite being on prophylactic treatment with low molecular weight heparin during her hospital stay. The nal histology of the resected specimen revealed an anovaginal stula tract centrally lined with colorectal type dysplastic epithelium, which formed well-differentiated glands producing mucin. This was positive for cytokeratin (CK) 20, MNF116 antibody and negative for CK7. There was also evidence of focal high-grade dysplasia within the anal sphincter. The rectal mucosa showed chronic inammatory changes and there was no evidence of anal

squamous dysplasia. The nal surgical pathology diagnosis after assessment by two consultant histopathologists (AA and NS) was a well-differentiated mucinous adenocarcinoma (estimated size of at least 35 mm). The small bowel mass showed serositis and some

Fig. 3. A photomicrograph of the histological specimen of the perianal lesion showing dysplastic colorectal type epithelium in the stula tract under high power magnication.

CASE REPORT OPEN ACCESS

M. Alfa-Wali et al. / International Journal of Surgery Case Reports 4 (2013) 579582 581

Fig. 4. The examination under anaesthetic of the anorectum at the time of resection showing evidence of residual stula with mucin expressible from the vaginal end of the stula.

granulomas in keeping with CD. The margins were clear with no lymph node involvement. Hence, the patient did not require any further adjuvant therapy. 3. Discussion Both ano-vaginal and recto-vaginal stulas are known to occur in patients with CD. They occur in approximately a quarter of females with CD.1 The processes behind these have been suggested to be due to factors such as the inammatory nature of the disease and transmural rectal involvement.2,3 Moreover, malignancy complicates long standing CD, thought to be secondary to constant mucosal regeneration which could lead to dysplasia and subsequently neoplasia.4,5 An incidence of 0.7 for carcinoma arising in a stula in CD has been reported from the patient series of Ky and colleagues.4 CD as with ulcerative colitis (UC) is known to be associated with the risk of developing colorectal cancer (CRC). The risk in CD can be up to 6-fold that of the general population for developing CRC and is recognised to be associated with a long duration of disease.6 Ano-rectal stulas in CD have been reported as occurring between 25 and 60 percent in disease affecting the terminal ileum and rectum respectively.4 However malignant transformation complicating an anal stula is very rare. Not unexpectedly the average age of presentation for a stula with CD is relatively early compared to the presentation of carcinoma.4 The reported cases of carcinoma arising from CD stulas have been in patients with CD for a period of approximately 20 years,4,7 as in the case of our patient. Early reports have been made about recto-vaginal stulas occurring more commonly in severe colonic CD.8 A case matched study of perianal stulous CD with and without CRC by Sobala et al.9 showed a signicant association of cancer in long standing stulas for a median period of 11 years. This was similar to the ndings of a systematic review of malignant cases of CD stulas.10 The pathogenesis of stulas in general is unknown. The development of carcinoma arising in CD stulas was initially thought to be squamous cell beginning from the squamous epithelium of the stula tract. Suggestions have also been made of origins of the mucinous adenocarcinomas originating from the anal glands.4 However, in the case presented here there was no histological evidence of squamous cell invasion or direct involvement of the anal glands leading to the development of carcinoma. The origins of

adenocarcinomas associated with stulas in CD have been debatable. Nishigami et al.11 performed immuno-histological studies using CK20 and mucins and established adenocarcinomas in CD stulas are associated with rectal type mucosa. Our immunohistochemical ndings also support this. Our case is similar to that of Smith et al.7 who reported a perianal mass in an elderly woman with extensive perianal and vulvar CD, that revealed a mucinous adenocarcinoma. The authors suggested the colonic epithelialization of the stula tract might have dysplastic potential that subsequently leads to development of mucinous adenocarcinoma without an underlying rectal cancer. Mucinous carcinomas in CD in a stula tract have been reported.4,5,7,1214 In the case presented by Freeman et al.,15 the patient had recurrent episodes of perianal and rectal stulas, which was not the situation in our patient. A previously reported case of mucinous carcinoma occurring in a stula tract in CD was thought to be associated with immunosuppressants such as azathioprine.10 In our case, cancer had originated de novo in a CD stula without rectal or anal mucosa involvement. Perhaps, our patient may have an additional predisposition to cancer because of her previous diagnosis of cervical cancer and possibly human papilloma virus exposure. The effects of immunosuppressive drugs cannot also be discounted as possibly playing a role. Persistent non-healing stulas in CD should alert the clinician to underlying malignancy.16 4. Conclusion Thorough surveillance of the perianal region and stula tracts should be incorporated with an EUA and biopsy in patients with perianal CD especially when there is no clinical suspicion of malignancy. Conict of interest statement There are no conicts of interest to disclose. Funding No funding has been received for this manuscript. Ethical approval Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal on request. Author contributions MAW, AAg drafted the manuscript; AA, YM and AM provided signicant advice in writing the manuscript. AM conceived the idea of writing the case report. All authors read and approved the nal manuscript. Acknowledgement Dr. Nigel Scott, Consultant Pathologist, at St James University Hospital, Leeds, UK for the review of the histology slides. References
1. Heyen F, Winslet MC, Andrews H, Alexander-Williams J, Keighley MR. Vaginal stulas in Crohns disease. Diseases of the Colon and Rectum 1989;32(5):37983. 2. Rothenberger DA, Goldberg SM. The management of rectovaginal stulas. Surgical Clinics of North America 1983;63(1):6179.

CASE REPORT OPEN ACCESS

582 M. Alfa-Wali et al. / International Journal of Surgery Case Reports 4 (2013) 579582 Journal of Gastrointestinal Surgery: Ofcial Journal of the Society for Surgery of the Alimentary Tract 2010;14(1):6673. Nishigami T, Kataoka TR, Ikeuchi H, Torii I, Sato A, Tomita N, et al. Adenocarcinomas associated with perianal stulas in Crohns disease have a rectal, not an anal, immunophenotype. Pathology 2011;43(1):369. Chaikhouni A, Regueyra FI, Stevens JR. Adenocarcinoma in perineal stulas of Crohns disease. Diseases of the Colon and Rectum 1981;24(8): 63943. Melichar B, Bures J, Dedic K. Anorectal carcinoma after iniximab therapy in Crohns disease: report of a case. Diseases of the Colon and Rectum 2006;49(8):122833. Zagoni T, Peter Z, Sipos F, Dichazi C, Tarjan Z, Dobo I, et al. Carcinoma arising in enterocutan stulas of Crohns disease patients: description of two cases. International Journal of Colorectal Disease 2006;21(5):4614. Freeman HJ, Perry T, Webber DL, Chang SD, Loh MY. Mucinous carcinoma in Crohns disease originating in a stulous tract. World Journal of Gastrointestinal Oncology 2010;2(7):30710. Inamdar NV, Schwarz P, Bailey HR, Skibber JM, Rich TA, Sellin J. Development of mutinous adenocarcinoma in chronic Crohns disease stulas without luminal involvement. Inammatory Bowel Diseases 1995;1(4):2803. 3. Radcliffe AG, Ritchie JK, Hawley PR, Lennard-Jones JE, Northover JM. Anovaginal and rectovaginal stulas in Crohns disease. Diseases of the Colon and Rectum 1988;31(2):949. 4. Ky A, Sohn N, Weinstein MA, Korelitz BI. Carcinoma arising in anorectal stulas of Crohns disease. Diseases of the Colon and Rectum 1998;41(8):9926. 5. Laurent S, Barbeaux A, Detroz B, Detry O, Louis E, Belaiche J, et al. Development of adenocarcinoma in chronic stula in Crohns disease. Acta Gastroenterologica Belgica 2005;68(1):98100. 6. Weedon DD, Shorter RG, Ilstrup DM, Huizenga KA, Taylor WF. Crohns disease and cancer. The New England Journal of Medicine 1973;289(21):1099103. 7. Smith R, Hicks D, Tomljanovich PI, Lele SB, Rajput A, Dunn KB. Adenocarcinoma arising from chronic perianal Crohns disease: case report and review of the literature. The American Surgeon Journal 2008;74(1):5961. 8. Bagby RJ, Clements Jr JL, Patrick JW, Rogers JV, Weens HS. Genitourinary complications of granulomatous bowel disease. American Journal of Roentgenology, Radium Therapy and Nuclear Medicine 1973;117(2):297306. 9. Sobala A, Herbst F, Novacek G, Vogelsang H. Colorectal carcinoma and preceding stula in Crohns disease. Journal of Crohns and Colitis 2010;4(2):18993. 10. Thomas M, Bienkowski R, Vandermeer TJ, Trostle D, Cagir B. Malignant transformation in perianal stulas of Crohns disease: a systematic review of literature.

11.

12.

13.

14.

15.

16.

Open Access This article is published Open Access at sciencedirect.com. It is distributed under the IJSCR Supplemental terms and conditions, which permits unrestricted non commercial use, distribution, and reproduction in any medium, provided the original authors and source are credited.